| [1] |
Patel V, Singh N, Saksena AK, et al. A comparative assessment of intranasal and oral dexmedetomidine for procedural sedation in pediatric dental patients[J]. J Indian Soc Pedod Prev Dent, 2018, 36(4): 370-375. DOI: 10.4103/jisppd.Jisppd_40_18. |
| [2] |
Wu X, Hang LH, Wang H, et al. Intranasally administered adjunctive dexmedetomidine reduces perioperative anesthetic requirements in general anesthesia[J]. Yonsei Med J, 2016, 57(4): 998-1005. DOI: 10.3349/ymj.2016.57.4.998. |
| [3] |
Chrysostomou C, Komarlu R, Lichtenstein S, et al. Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease[J]. Intensive Care Med, 2010, 36(5): 836-842. DOI: 10.1007/s00134-010-1782-z. |
| [4] |
Kiski D, Malec E, Schmidt C. Use of dexmedetomidine in pediatric cardiac anesthesia[J]. Curr Opin Anaesthesiol, 2019, 32(3): 334-342. DOI: 10.1097/aco.0000000000000731. |
| [5] |
Schwartz LI, Twite M, Gulack B, et al. The perioperative use of dexmedetomidine in pediatric patients with congenital heart disease: an analysis from the Congenital Cardiac Anesthesia Society-Society of Thoracic Surgeons Congenital Heart Disease Database[J]. Anesth Analg, 2016, 123(3): 715-721. DOI: 10.1213/ANE.0000000000001314. |
| [6] |
Pan W, Wang Y, Lin L, et al. Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a Meta-analysis[J]. Paediatr Anaesth, 2016, 26(3): 239-248. DOI: 10.1111/pan.12820. |
| [7] |
Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans[J]. Anesthesiology, 2000, 93(2): 382-394. DOI: 10.1097/00000542-200008000-00016. |
| [8] |
Lee JS, Park SJ, Min KT. Dexmedetomidine for rigid bronchoscopy in an infant with tracheal web after ventricular septal defect patch repair[J]. Yonsei Med J, 2014, 55(2): 539-541. DOI: 10.3349/ymj.2014.55.2.539. |
| [9] |
Cai Y, Li W, Chen K. Efficacy and safety of spontaneous ventilation technique using dexmedetomidine for rigid bronchoscopic airway foreign body removal in children[J]. Paediatr Anaesth, 2013, 23(11): 1048-1053. DOI: 10.1111/pan.12197. |
| [10] |
Mahmoud M, Jung D, Salisbury S, et al. Effect of increasing depth of dexmedetomidine and propofol anesthesia on upper airway morphology in children and adolescents with obstructive sleep apnea[J]. J Clin Anesth, 2013, 25(7): 529-541. DOI: 10.1016/j.jclinane.2013.04.011. |
| [11] |
Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J]. Anesthesiology. 2003, 98(2): 428-436. DOI: 10.1097/00000542-200302000-00024. |
| [12] |
Peng K, Li J, Ji F, et al. Dexmedetomidine compared with propofol for pediatric sedation during cerebral angiography[J]. J Res Med Sci, 2014, 19(6): 549-554.
|
| [13] |
Bao N, Tang B. Organ-protective effects and the underlying mechanism of dexmedetomidine[J]. Mediators Inflamm, 2020, 2020: 6136105. DOI: 10.1155/2020/6136105. |
| [14] |
Park SJ, Shin S, Kim SH, et al. Comparison of dexmedetomidine and fentanyl as an adjuvant to ropivacaine for postoperative epidural analgesia in pediatric orthopedic surgery[J]. Yonsei Med J, 2017, 58(3): 650-657. DOI: 10.3349/ymj.2017.58.3.650. |
| [15] |
Alam A, Suen KC, Hana Z, et al. Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon[J]. Neurotoxicol Teratol, 2017, 60: 102-116. DOI: 10.1016/j.ntt.2017.01.001. |
| [16] |
Perez-Zoghbi JF, Zhu W, Grafe MR, et al. Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats[J]. Br J Anaesth, 2017, 119(3): 506-516. DOI: 10.1093/bja/aex222. |
| [17] |
Wang X, Shan Y, Tang Z, et al. Neuroprotective effects of dexmedetomidine against isoflurane-induced neuronal injury via glutamate regulation in neonatal rats[J]. Drug Des Devel Ther, 2019, 13: 153-160. DOI: 10.2147/dddt.S163197. |
| [18] |
Bell MT, Puskas F, Bennett DT, et al. Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion[J]. J Thorac Cardiovasc Surg, 2014, 147(1): 500-506. DOI: 10.1016/j.jtcvs.2013.07.043. |
| [19] |
Sanders RD, Xu J, Shu Y, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats[J]. Anesthesiology, 2009, 110(5): 1077-1085. DOI: 10.1097/ALN.0b013e31819daedd. |
| [20] |
Koo E, Oshodi T, Meschter C, et al. Neurotoxic effects of dexmedetomidine in fetal cynomolgus monkey brains[J]. J Toxicol Sci, 2014, 39(2): 251-262. DOI: 10.2131/jts.39.251. |
| [21] |
Duan X, Li Y, Zhou C, et al. Dexmedetomidine provides neuroprotection: impact on ketamine-induced neuroapoptosis in the developing rat brain[J]. Acta Anaesthesiol Scand, 2014, 58(9): 1121-1126. DOI: 10.1111/aas.12356. |
| [22] |
Sifringer M, von Haefen C, Krain M, et al. Neuroprotective effect of dexmedetomidine on hyperoxia-induced toxicity in the neonatal rat brain[J]. Oxid Med Cell Longev, 2015, 2015: 530371. DOI: 10.1155/2015/530371. |
| [23] |
Su F, Gastonguay MR, Nicolson SC, et al. Dexmedetomidine pharmacology in neonates and infants after open heart surgery[J]. Anesth Analg, 2016, 122(5): 1556-1566. DOI: 10.1213/ane.0000000000000869. |
| [24] |
Chrysostomou C, Schulman SR, Herrera Castellanos M, et al. A phase Ⅱ/Ⅲ multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates[J]. J Pediatr, 2014, 164(2): 276-282.e1-e3. DOI: 10.1016/j.jpeds.2013.10.002. |
| [25] |
Sun Y, Lu Y, Huang Y, et al. Is dexmedetomidine superior to midazolam as a premedication in children? A Meta-analysis of randomized controlled trials[J]. Paediatr Anaesth, 2014, 24(8): 863-874. DOI: 10.1111/pan.12391. |
| [26] |
Sheta SA, Al-Sarheed MA, Abdelhalim AA, et al. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial[J]. Paediatr Anaesth, 2014, 24(2): 181-189. DOI: 10.1111/pan.12287. |
| [27] |
Savla JR, Ghai B, Bansal D, et al. Effect of intranasal dexmedetomidine or oral midazolam premedication on sevoflurane EC50 for successful laryngeal mask airway placement in children: a randomized, double-blind, placebo-controlled trial[J]. Paediatr Anaesth, 2014, 24(4): 433-439. DOI: 10.1111/pan.12358. |
| [28] |
Yao Y, Qian B, Chen Y, et al. Intranasal dexmedetomidine premedication reduces the minimum alveolar concentration of sevoflurane for tracheal intubation in children: a randomized trial[J]. J Clin Anesth, 2014, 26(4): 309-314. DOI: 10.1016/j.jclinane.2013.12.012. |
| [29] |
Di M, Yang Z, Qi D, et al. Intravenous dexmedetomidine pre-medication reduces the required minimum alveolar concentration of sevoflurane for smooth tracheal extubation in anesthetized children: a randomized clinical trial[J]. BMC Anesthesiol, 2018, 18(1): 9. DOI: 10.1186/s12871-018-0469-9. |
| [30] |
Lee-Archer PF, von Ungern-Sternberg BS, Reade M, et al. The effect of dexmedetomidine on postoperative behaviour change in children: a randomised controlled trial[J]. Anaesthesia, 2020, 75(11): 1461-1468. DOI: 10.1111/anae.15117. |
| [31] |
She YJ, Xie GT, Tan YH, et al. A prospective study comparing the onset and analgesic efficacy of different concentrations of levobupivacaine with/without dexmedetomidine in young children undergoing caudal blockade[J]. J Clin Anesth, 2015, 27(1): 17-22. DOI: 10.1016/j.jclinane.2014.09.005. |
| [32] |
Trifa M, Tumin D, Tobias JD. Dexmedetomidine as an adjunct for caudal anesthesia and analgesia in children[J]. Minerva Anestesiol, 2018, 84(7): 836-847. DOI: 10.23736/S0375-9393.18.12523-5. |
| [33] |
Fares KM, Othman AH, Alieldin NH. Efficacy and safety of dexmedetomidine added to caudal bupivacaine in pediatric major abdominal cancer surgery[J]. Pain physician, 2014, 17(5): 393-400.
|
| [34] |
Al-Zaben KR, Qudaisat IY, Alja′bari AN, et al. The effects of caudal or intravenous dexmedetomidine on postoperative analgesia produced by caudal bupivacaine in children: a randomized controlled double-blinded study[J]. J Clin Anesth, 2016, 33: 386-394. DOI: 10.1016/j.jclinane.2016.04.049. |
| [35] |
Lundblad M, Marhofer D, Eksborg S, et al. Dexmedetomidine as adjunct to ilioinguinal/iliohypogastric nerve blocks for pediatric inguinal hernia repair: an exploratory randomized controlled trial[J]. Paediatr Anaesth, 2015, 25(9): 897-905. DOI: 10.1111/pan.12704. |
| [36] |
Cummings BM, Cowl AS, Yager PH, et al. Cardiovascular effects of continuous dexmedetomidine infusion without a loading dose in the pediatric intensive care unit[J]. J Intensive Care Med, 2015, 30(8): 512-517. DOI: 10.1177/0885066614538754. |
| [37] |
Piastra M, Pizza A, Gaddi S, et al. Dexmedetomidine is effective and safe during NIV in infants and young children with acute respiratory failure[J]. BMC Pediatr, 2018, 18(1): 282. DOI: 10.1186/s12887-018-1256-y. |
| [38] |
Ahmed SS, Unland T, Slaven JE, et al. Successful use of intravenous dexmedetomidine for magnetic resonance imaging sedation in autistic children[J]. South Med J, 2014, 107(9): 559-564. DOI: 10.14423/smj.0000000000000160. |
| [39] |
Nagoshi M, Reddy S, Bell M, et al. Low-dose dexmedetomidine as an adjuvant to propofol infusion for children in MRI: a double-cohort study[J]. Paediatr Anaesth, 2018, 28(7): 639-646. DOI: 10.1111/pan.13400. |
| [40] |
Gumus H, Bayram AK, Poyrazoglu HG, et al. Comparison of effects of different dexmedetomidine and chloral hydrate doses used in sedation on electroencephalography in pediatric patients[J]. J Child Neurol, 2015, 30(8): 983-988. DOI: 10.1177/0883073814549582. |
| [41] |
Li BL, Yuen VM, Song XR, et al. Intranasal dexmedetomidine following failed chloral hydrate sedation in children[J]. Anaesthesia, 2014, 69(3): 240-244. DOI: 10.1111/anae.12533. |
| [42] |
Mason KP, Robinson F, Fontaine P, et al. Dexmedetomidine offers an option for safe and effective sedation for nuclear medicine imaging in children[J]. Radiology, 2013, 267(3): 911-917. DOI: 10.1148/radiol.13121232. |
| [43] |
Lin Y, Zhang R, Shen W, et al. Dexmedetomidine versus other sedatives for non-painful pediatric examinations: a systematic review and Meta-analysis of randomized controlled trials[J]. J Clin Anesth, 2020, 62: 109736. DOI: 10.1016/j.jclinane.2020.109736. |
| [44] |
Fritock MD, Ing RJ, Twite MD. Cardiac arrest in 2 neonates receiving amiodarone and dexmedetomidine[J]. J Cardiothorac Vasc Anesth, 2017, 31(6): 2135-2138. DOI: 10.1053/j.jvca.2017.02.176. |
| [45] |
Whalen LD, Di Gennaro JL, Irby GA, et al. Long-term dexmedetomidine use and safety profile among critically ill children and neonates[J]. Pediatr Crit Care Med, 2014, 15(8): 706-714. DOI: 10.1097/pcc.0000000000000200. |
| [46] |
Kubota T, Fukasawa T, Kitamura E, et al. Epileptic seizures induced by dexmedetomidine in a neonate[J]. Brain Dev, 2013, 35(4): 360-362. DOI: 10.1016/j.braindev.2012.05.011. |
| [47] |
Kose EA, Bakar B, Kasimcan O, et al. Effects of intracisternal dexmedetomidine on cerebral neuronal cells in rat: a preliminary study[J]. Turk Neurosurg, 2013, 23(1): 38-44. DOI: 10.5137/1019-5149.Jtn.6261-12.2. |
| [48] |
Fagerholm V, Haaparanta M, Scheinin M. Α2-adrenoceptor regulation of blood glucose homeostasis[J]. Basic Clin Pharmacol Toxicol, 2011, 108(6): 365-370. DOI: 10.1111/j.1742-7843.2011.00699.x. |
| [49] |
Görges M, Poznikoff AK, West NC, et al. Effects of dexmedetomidine on blood glucose and serum potassium levels in children undergoing general anesthesia: a secondary analysis of safety endpoints during a randomized controlled trial[J]. Anesth Analg, 2019, 129(4): 1093-1099. DOI: 10.1213/ane.0000000000004154. |
| [50] |
Li S, Liu H, Zhang J, et al. The 95% effective dose of intranasal dexmedetomidine sedation for pulmonary function testing in children aged 1-3 years: a biased coin design up-and-down sequential method[J]. J Clin Anesth, 2020, 63: 109746. DOI: 10.1016/j.jclinane.2020.109746. |